Science Strategic Acquisition Charlie, the third blank check company formed by venture firm Science Inc. targeting consumer tech, filed on Friday with the SEC to raise up to $125 million in an initial public offering.
The Santa Monica, CA-based company plans to raise $125 million by offering 12.5 million units at $10. Each unit consists of one share of common stock and one-fourth of a warrant, exercisable at $11.50. At the proposed deal size, Science Strategic Acquisition Charlie would command a market value of $156 million.
The company is led by CEO and Chairman Michael Jones, CFO Thomas Dare, and President Peter Pham, who collectively co-founded studio and venture fund Science Inc. and have served as Managing Directors since 2011. Science Strategic Acquisition Bravo's search for a target will be differentiated and targeted on the areas in which the management team has expertise in driving business transformations and creating value for investors: Direct-to-consumer (D2C) Brands, D2C Services & Marketplaces, and Mobile & Social Entertainment. The group's other SPACs include Science Strategic Acquisition Alpha (SSAAU) and Science Strategic Acquisition Bravo (SCIBU).
Science Strategic Acquisition Charlie was founded in 2021 and plans to list on the Nasdaq under the symbol SCICU. Credit Suisse is the sole bookrunner on the deal.
